Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels

James R. Pauly, Michael J. Marks, Scott F. Robinson, Jennifer L. Van De Kamp, Allan C. Collins

Research output: Contribution to journalArticlepeer-review

129 Scopus citations

Fingerprint

Dive into the research topics of 'Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science